Karl Truman Law Office focuses on high-quality client service in and around Louisville, Kentucky, and Jeffersonville, Indiana

CPI Consulting CEO for over 30 years reveals success strategies for "Planning the Life You Desire ~ Living the Life You Deserve: Creating & Achieving Goals That Matter Most"

SS.stew is one such example who transformed his dreams into goals and ultimately achieved his desired success. A young 21 year boy, who began creating songs and mastered his craft by learning music from YouTube tutorials. "Icy and Wavy"...

The tenth anniversary - and final - issue is now available. The website will be shutting down this quarter.

BWW – Best Wine of the World Competition is the largest wine competition in the world, whether measured by the number of wines, the number of consumers involved or the judges taking part.

After helping entrepreneurs find success in business, Ashely is ready to share her knowledge with a larger audience.

This publication provides comprehensive construction forecasts for a broad range of segments in the U.S. and Canada, as well as information on key drivers and geographic performance.

In this whitepaper, authors explore the idea that the equipment fleet is a strategic asset and should be managed as one.

In partnership with Brand Apiary & Hollywood Swag Bag

Premier business school news site unveils community resource to increase odds of acceptance

Annual invitation for nominations for digital innovation across business and IT

Discussion Will Spotlight Why Women Should Take the Lead in Politics Awards Presentation Will Honor Local Notables

inboxAds Gives Publishers 10% Bonus Revenue in Their Fight Against COVID-19, Says Company CEO

bestmarijuanaguide.com, the premier online directory for cannabis products, suppliers, and dispensaries has announced it launch on the morning of April 1st, 2020.

Recently Northwest Fisheries Enhancement Saved over 400,000 Rainbow Trout from Regulators During a Downturn in Markets from COVID-19

Fourth eBook in AM Focus 2020 Series Provides Unique Insights into 3D Printing with Technical Ceramics, Composites, Advanced Polymers and Refractory Metals

Poets&Quants Partner Publisher Hub takes a deep dive into all business offerings from Gies

Many homeowners struggling financially in the coronavirus pandemic worry mortgage servicers will require them to repay mortgage bills all at once.

Shareholders will be ecstatic, with their stake up 30% over the past week following ObsEva SA's (NASDAQ:OBSV) latest...

(Bloomberg) -- Wall Street’s biggest firms are divided on where markets are heading to next.While most risk assets are well off their mid-March lows, when uncertainty about the global impact of the coronavirus outbreak was at its peak, there is little consensus on what is to follow. At the core of the debate is the long-term effectiveness of the massive stimulus from central banks and governments.When $8 Trillion in Global Fiscal Stimulus Still Isn’t EnoughCitigroup Inc., for one, doesn’t get the “puzzling” rise in stocks.“Extensive policy response, led by ample liquidity provided by central banks, likely contributed to the move in the markets,” economists including Igor Cesarec and Catherine Mann wrote in a note Thursday. “However, since it is not clear that markets can be propped up indefinitely, caution is warranted. Risk assets could be fragile once the cold, hard economic reality hits again.”On the other hand, JPMorgan Chase & Co. sees the stock market advance as justified -- and one which can continue.“While the collapse in economic activity is historic, so too is the global policy response to cushion the impact and support a recovery,” strategists led by Marko Kolanovic wrote in a note Thursday. “We expect risky assets to continue to recover as economies reopen and given the unprecedented policy support, though we expect a moderation in the pace of gains.”Read about JPMorgan’s call in late March that markets were probably past the worst.The MSCI AC World Index has climbed about 25% since March 23 as investor sentiment warmed toward a slew of worldwide policy measures to offset the economic impact of the pandemic. The global gauge had fallen as much as 34% from its February high, when concerns about the virus reached a peak.Looking ForwardGoldman Sachs Group Inc. and Morgan Stanley largely see gains remaining intact, with caveats.Goldman attributes the market rise to a stabilization in virus infection rates and an improvement in measures of funding and liquidity stress. The firm has already said that equities price in macroeconomic performance over a two-year time horizon and investors may look past huge economic damage.“Markets will continue to look through bad news about the depth of the economic downturn if they can continue to hold on to their view that a sizable chunk of the recent damage will be reversed by the end of next year,” strategists including Zach Pandl wrote in a note Tuesday.And Morgan Stanley is also comfortable with the disparity between asset price performance and fundamentals, noting that markets tend to lead the economy and care more about rate of changes than absolute levels.“Divergences between the market and economy are common at economic extremes,” wrote strategists including Andrew Sheets in a note Thursday. “Rate of change is key – a ‘U’ shaped recovery is fine, a ‘W’ is not.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

European airlines are beginning to see faint glimmers of economic sunlight and preparing to come out of their coronavirus hibernation.Deutsche Lufthansa AG (OTCMKTS:DLAKY) on Friday said group airlines Lufthansa, Eurowings and SWISS will collectively reactivate 80 aircraft for June, doubling the operational fleet size to serve a total of 106 destinations. IAG Group this week said it plans to ramp up passenger service in July on the expectation that travel restrictions will ease and more people will start flying again. Both airlines have shrunk flight operations to less than 10% of their pre-crisis level as the pandemic caused the travel market to collapse.Most of the Lufthansa Group aircraft currently in service today are flying cargo or rescue missions for governments and travel operators to bring home tourists and other travelers stranded abroad by coronavirus travel bans. Lufthansa operates a dedicated fleet of freighters and is using many passenger planes for dedicated cargo operations too.With the outbreak past its crest in Europe, Lufthansa said it will gradually expand its flight schedule each month as Germany and other European countries loosen travel restrictions and open borders "We sense a great desire and longing among people to travel again. Hotels and restaurants are slowly opening, and visits to friends and family are in some cases being allowed again. With all due caution, we are now making it possible for people to catch up and experience what they had to do without for a long time. It goes without saying that the safety and health of our guests and employees are of the highest priority," said Harry Hohmeister, the head of commercial passenger airlines at Deutsche Lufthansa AG, in a statement.Starting in June, Group airlines will again fly to leisure destinations in Mallorca, Spain; the German island of Sylt; Rostock, Germany; and Crete, Greece. The June flight schedule will be published within a week.The company cautioned travelers to prepare for longer wait times at airport security checkpoints as authorities impose stricter hygiene regulations. And catering services on board will also remain restricted until further notice.Earlier this week, Lufthansa Group began requiring all passengers to wear face masks to help protect passengers and crew members from infection.Meanwhile, the parent company disclosed this week that it is negotiating with the German government for an emergency financial aid package worth 9 billion euros ($9.7 billion) to help fund operations and payroll until revenues pick up in a meaningful way.Germany privatized Lufthansa in the late 1990s.The relief package would include a secured loan and a non-voting equity stake of up to 25% for the government. Lufthansa would also be required to suspend future dividend payments as part of the deal.Lufthansa officials have warned the company may file for bankruptcy without stabilization aid. An issue under debate is the government's request for two board seats, which could give the government a say in how many workers to retain or other policies.Most of Lufthansa's workers are on leave and receiving aid under a government safety-net program.The International Air Transport Association has said governments need to do more to help airlines get through the worst crisis in aviation history because of the enormous number of jobs involved and because air travel is critical to reviving the global economy.Photo: Lufthansa AirlinesSee more from Benzinga * BLS Report: Six Years Of Trucking Sector Job Gains Have Disappeared * USA Truck Sees Green Shoots Amid Uncertainty; Shares Surge * California Targets Two Trading Companies Over Fuel Prices, But Diesel Isn't Part Of The Lawsuit(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Horrific news on lost jobs sends the Trump-o-meter to an unprecedented new low.

Norwegian Cruise Line says it's in danger of going out of business. Maybe that's not the worst thing for an industry of floating petri dishes.

Investors in Clean Energy Fuels Corp. (NASDAQ:CLNE) had a good week, as its shares rose 6.3% to close at US$2.11...

Douglas Boneparth, Bone Fide Wealth President, joined Yahoo Finance's Jen Rogers, Myles Udland, Dan Roberts, and Melody Hahm to discuss the best approach to retirement planning during the coronavirus pandemic.

As of Thursday evening, more than 40 percent of the funds remained available in the Paycheck Protection Progam

The latest data analyzed by The Block Research shows that bitcoin miners made 8% more revenue in April as compared to March, thanks to a gradual recovery in bitcoin’s price.The post Bitcoin miners made $412.5 million in revenue during April, new data indicates appeared first on The Block.

Could we see the yellow metal at $5,000 or even higher amid the coronavirus crisis? We invite you thus to read our today’s article and find out how high gold prices can go in this downturn.

Above: A Hydrogen Powered Truck from Nikola Corporation, Which Is Merging with VectoIQ Acquisition Corp. By John Jannarone Since the coronavirus crisis drove the market to multiyear lows, the flow of initial public offerings has ground to a veritable halt. That is, except, for special purpose acquisition companies, or SPACs. Some $2.7 billion has been […]

When tickets for the May 11 reopening of Shanghai Disneyland went on sale, they sold out within minutes. Park officials said they are taking "a deliberate approach”, such as requiring physical distancing and sharply reducing capacity. Jen Rogers, Myles Udland and Akiko Fujita discuss what the reopening of the first major theme park says about consumer demand post-coronavirus.

The move will help Southwest save cash at a time when U.S. airlines collectively burn more than $10 billion a month. Last month, rival United Airlines agreed to sell and lease back 22 planes to aircraft investor Bank of China Aviation. United, however, did not specify the size of the deal.

The market 'has been driven by sentiment recently' — and is overvalued, warns one veteran strategist.

Biopharma shares have outperformed the broader market year-to-date, giving rise to apprehension over whether a pullback is in the offing. An analyst at BofA Securities said Friday that now is the time to go from defensive to offensive in the sector, as quarantines are winding down in several parts of the globe.The Biopharma Analyst Analyst Geoff Meacham shortlisted Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Bristol-Myers Squibb Co (NYSE: BMY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and Amgen, Inc. (NASDAQ: AMGN) as biopharma stocks where he would put his money to work.The analyst has the following ratings and price targets for the shares: * Lilly: Buy/$165 * Vertex: Buy/$300 * Bristol-Myers Squibb: Buy/raised the price target from $75 to $80 * BioMarin: Buy/lifted price target from $110 to $120 * Amgen: Buy/price target increased from $265 to $2755 Reasons For BofA's Bullish Disposition BofA is increasingly bullish on the biopharma group due to the following factors, Meacham said: * Expectations for robust revenue growth of 6% in the second half of 2020 compared to the first-half, which is double that of the S&P 500's revenue growth. * Reasonable price-earnings for the stocks in the sector. * Many value-creating events lined up for the second half. * Lower policy risk stemming from goodwill earned from the COVID-19 pipeline. * A consistently positive FDA backdrop.Q1 Earnings Get 'A' Grade All of the big biotechs and major pharma companies reported both revenue and adjusted EPS beats in the first quarter, with Lilly and Vertex even raising some parts of their 2020 guidance, Meacham said.Citing slower new starts and forex headwinds, Bristol-Myers Squibb and BioMarin lowered their 2020 revenue guidance, but maintained their EPS guidance, the analyst said. Meacham expressed surprise at Merck & Co., Inc. (NYSE: MRK) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) lowering their 2020 revenue and adjusted EPS guidance, given his belief that oncology or orphan diseases wouldn't be as sensitive to COVID-19 disruption.See also: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Lilly One of The Higher Quality Stocks In BofA's Coverage Lilly is a source of differentiated growth given its early product cycle and diversified base business, including diabetes, immunology and immunotoxicology and migraine, and an advancing late-stage pipeline of potentially best-in-class or first-in-class therapies, Meacham said.The analyst said he likes Lily's potential for additional earnings growth in 2020-2021 and views Lilly as one of the higher quality stocks in his coverage despite its higher valuation. The prospects for 2021 look attractive, with selpercatinib potentially launching in non-small cell lung cancer and thyroid cancer by year's end, and tirzepatide approval in 2021 representing a "step change" for the diabetes franchise, he said. Consensus For Vertex To Move Higher? Vertex has a richer -- though well-deserved -- valuation, due to its differentiated growth profile, Meacham said.Given that Vertex's commercial execution is largely unaffected by the COVID-19 pandemic, the analyst said investors will begin to look forward to 2021 sooner than for other companies with more commercial risk.BofA expects consensus estimates to continue to move higher, making Vertex's valuation even more attractive.Bristol-Myers Has Highly Differentiated Growth With an estimated 8% revenue growth and 19% EPS growth in 2021 compared to 5-6% and 12%, respectively, for peers, and with six new launches expected this year, 2020 is shaping up to be a very robust period for Bristol-Myers despite the ongoing COVID-19 headwinds, Meacham said. The analyst said the company's growth looks highly differentiated.An increasingly diversified product mix and beatable launch expectations position the company for meaningful upside to consolidated P&L, with improving synergies, he said. BioMarin's 'Game-Changing' Late-Stage Pipeline BioMarin's late-stage pipeline in valrox and vosoritide have improved its growth outlook, Meacham said.The analyst termed the company's late-stage pipeline as "game-changing." The second-half launch of Roctavian is the most important catalyst for the company this year, with the product likely to accelerate the company's already above-average growth profile, he said. "We see BioMarin as one of the higher quality names in our coverage universe given its clean growth story and it remains our SMid cap top pick." Amgen Looks To New Product Growth To Compensate For Legacy Product Erosion The long-term outlook for Amgen's Otezla is improving given the recently announced Phase 3 data for mild-to-moderate psoriasis, Meacham said.The company rapidly refocused its story from legacy product erosion to new product growth with the acquisition of Otezla from the Bristol/Celgene deal, the analyst said. "Since then Amgen's growth profile has only improved, led by an expanded addressable market for Otezla, outperforming Amgen Biosimilars and Evenity franchises, aggressive formulary negotiation for Aimovig, and an exciting pipeline in AMG 510 and tezepelumab looking to contribute as soon as 2021." The Price Action The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) was last seen trading up 1.25% to 128.76, adding to its 5.6% year-to-date gain. Related Link: The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace See more from Benzinga * The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda * The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500 * The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

GitHub on Wednesday announced two new security features designed to help developers identify vulnerabilities and potential secrets in their code.

The company announced several new products at its Satellite virtual conference, including ones aimed at helping customers write and consume more secure code.

read more

A large-scale attack campaign has targeted over 900,000 WordPress websites through vulnerabilities in plugins and themes, WordPress security company Defiant revealed this week.

read more

The Czech Republic and the United States have signed a joint declaration Wednesday for cooperating on security of 5G technology.

read more

Researchers have found another vulnerability in software made by Schneider Electric that is similar to the one exploited by the notorious Stuxnet malware.

read more

Naikon, a Chinese APT group that disappeared after its activities were disclosed in 2015, has been rediscovered and may have remained active but unrecognized since the 2015 reports. Researchers have uncovered evidence of a five-year stealth campaign against similar targets in the same geographical area that they believe to be conducted by Naikon.

read more

Recorded Future this week announced the availability of Express, a free web browser extension designed to help security teams prioritize vulnerability patching and alerts from security information and event management (SIEM) tools.

read more

Cisco’s Talos threat intelligence and research group revealed on Wednesday that one of its researchers discovered a critical remote code execution vulnerability in the CODESYS Control SoftPLC industrial controller software.

read more

New York state's top prosecutor on Thursday announced that the company Zoom would improve security measures, after flaws were detected as the video conferencing platform soared in popularity amid the coronavirus pandemic.

read more